Results 161 to 170 of about 13,220 (219)

Evaluation of the In Vitro Synergistic Activity of Ceftazidime/Avibactam Against Stenotrophomonas maltophilia Strains in Planktonic and Biofilm Cell Cultures. [PDF]

Pharmaceuticals (Basel)
Damar-Çelik D, Mataraci-Kara E, İstanbullu-Tosun A, Çakmak SM, Sümbül B, Özbek-Çelik B.   +5 more
europepmc   +1 more source

Cerebrospinal fluid and plasma pharmacokinetics of ceftazidime/avibactam in a neurocritical patient with CRKP intracranial infection and augmented renal clearance. [PDF]

JAC Antimicrob Resist
Huang SM, Chen QH, Wang W, Wang YM, Wei YW, Qu Q, Zhang HN, Qu J.   +7 more
europepmc   +1 more source

<i>In vivo</i> selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing <i>E. coli</i> ST410. [PDF]

Antimicrob Agents Chemother
Jousset AB, Girlich D, Oueslati S, Birer A, Delaval A, Guyot C, Rezzoug I, Emeraud C, Naas T, Bonnin RA, Dortet L.   +10 more
europepmc   +1 more source

Exposure to ceftazidime-avibactam induced antimicrobial resistance and enhanced virulence in a <i>Klebsiella pneumoniae</i> strain. [PDF]

iScience
Li J, Wang H, Liu Z, Xia Y, Hu Y, Wang H, Xia F, Zou M.   +7 more
europepmc   +1 more source

Combination of Ceftazidime-Avibactam and Aztreonam Effectively Treated Post-Cardiac Surgery Pneumonia Caused by Hypervirulent KPC- and NDM-Producing <i>Klebsiella pneumoniae</i>: A Case Report. [PDF]

Infect Drug Resist
Wei Q, Cong R, Shen C, Chen C, Cao Z, Ren C, Liu T.   +6 more
europepmc   +1 more source

Molecular epidemiology of carbapenem-resistant hypervirulent <i>Klebsiella pneumoniae</i>: risk factors and resistance mechanism of ceftazidime/avibactam in China. [PDF]

Front Cell Infect Microbiol
Wang N, Deng L, Li H, Jia N, Peng X, Chang J, Hao J, Tang J, Lei C, Wang B, Liu J, Zhang W.   +11 more
europepmc   +1 more source

Ceftazidime-Avibactam Regimens for the Treatment of Bacteremic and Non-Bacteremic Episodes of Carbapenemase-Producing Enterobacterales Infections in Immunosuppressed Patients. [PDF]

Pathogens
Herrera F, Torres D, Leone M, Castro MG, Camelo JL, Temporiti E, Grippo N, Relloso S, Bonvehí P.   +8 more
europepmc   +1 more source

The impact of ceftazidime-avibactam on 30-day mortality in the treatment of OXA-48 producing <i>Enterobacterales</i> infections: a systematic review and meta-analysis. [PDF]

JAC Antimicrob Resist
Foo AL, Young B, Ng OT, Vasoo S.
europepmc   +1 more source

Landscape of resistance to ceftolozane/tazobactam and ceftazidime/avibactam in strains of Pseudomonas aeruginosa: a genomic approach in strains without selection pressure in a tertiary-care paediatric hospital in Mexico. [PDF]

BMC Infect Dis
A Méndez HE, Merida-Vieyra J, Aparicio-Ozores G, Hernández-Durán M, Méndez-Tenorio A, Tapia-Reyes A, Bautista-Hernandez R, Juárez-Hinojos D, Aquino-Andrade A.   +8 more
europepmc   +1 more source

Successful dual therapy of aztreonam and ceftazidime-avibactam for multidrug-resistant <i>Stenotrophomonas maltophilia</i> infection in a preterm neonate: A life-saving approach. [PDF]

J Int Med Res
Alghamdi AO, Algethami AS, Aljuaeed MS, Alkhammash FM, Almalki FM, Alharthi SA, Aljaed NM, Abosabie SA, Abosabie SA, Kamal NM.   +9 more
europepmc   +1 more source